Alternative strategies for Chlamydia treatment: Promising non-antibiotic approaches
Open Access
- 23 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 987662
Abstract
Chlamydia is an obligate intracellular bacterium where most species are pathogenic and infectious, causing various infectious diseases and complications in humans and animals. Antibiotics are often recommended for the clinical treatment of chlamydial infections. However, extensive research has shown that antibiotics may not be sufficient to eliminate or inhibit infection entirely and have some potential risks, including antibiotic resistance. The impact of chlamydial infection and antibiotic misuse should not be underestimated in public health. This study explores the possibility of new therapeutic techniques, including a review of recent studies on preventing and suppressing chlamydial infection by non-antibiotic compounds.Keywords
Funding Information
- Natural Science Foundation of Hunan Province
This publication has 150 references indexed in Scilit:
- Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretionThe Journal of Antibiotics, 2012
- Azithromycin antimicrobial resistance and genitalChlamydia trachomatisinfection: duration of therapy may be the key to improving efficacySexually Transmitted Infections, 2012
- Spider Venom Peptides for Gene Therapy of Chlamydia InfectionAntimicrobial Agents and Chemotherapy, 2011
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I InterferonsCell, 2011
- Antibiotic Resistance in ChlamydiaeFuture Microbiology, 2010
- Evaluation of WLBU2 Peptide and 3- O -Octyl- sn -Glycerol Lipid as Active Ingredients for a Topical Microbicide Formulation Targeting Chlamydia trachomatisAntimicrobial Agents and Chemotherapy, 2010
- Severe Tryptophan Starvation Blocks Onset of Conventional Persistence and Reduces Reactivation of Chlamydia trachomatisInfection and Immunity, 2007
- Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseasesProceedings of the National Academy of Sciences, 2007
- A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatisProceedings of the National Academy of Sciences, 2006
- Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycleMolecular Microbiology, 2006